Outcomes After Percutaneous Coronary Intervention in Patients With a History of Cerebrovascular Disease: Insights From the Blue Cross Blue Shield of Michigan Cardiovascular Consortium

Overview

Journal Circ Cardiovasc Interv

Specialty Cardiology & Vascular Diseases

Date 2018 Jun 14

PMID 29895601

Citations 5

Authors

Chris Song

Devraj Sukul

Milan Seth

David Wohns

Simon R Dixon

Nicklaus K Slocum

Hitinder S Gurm

Affiliations

Soon will be listed here.

Abstract

Background: Because of shared risk factors between coronary artery disease and cerebrovascular disease, patients with a history of transient ischemic attack (TIA) or stroke are at greater risk of developing coronary artery disease, which may require percutaneous coronary intervention (PCI). However, there remains a paucity of research examining outcomes after PCI in these patients.

Methods And Results: We analyzed consecutive patients who underwent PCI between January 1, 2013, and March 31, 2016, at 47 Michigan hospitals and identified those with a history of TIA/stroke. We used propensity score matching to adjust for differences in baseline characteristics and compared in-hospital outcomes between patients with and without a history of TIA/stroke. We compared rates of 90-day readmission and long-term mortality in a subset of patients. Among 98 730 patients who underwent PCI, 10 915 had a history of TIA/stroke. After matching (n=10 618 per group), a history of TIA/stroke was associated with an increased risk of in-hospital stroke (adjusted odds ratio, 2.04; 95% confidence interval, 1.41-2.96; <0.001). There were no differences in the risks of other in-hospital outcomes. In a subset of patients with postdischarge data, a history of TIA/stroke was associated with increased risks of 90-day readmission (adjusted odds ratio, 1.22; 95% confidence interval, 1.09-1.38; <0.001) and long-term mortality (hazard ratio, 1.23; 95% confidence interval, 1.07-1.43; =0.005).

Conclusions: A history of TIA/stroke was common in patients who underwent PCI and was associated with increased risks of in-hospital stroke, 90-day readmission, and long-term mortality. Given the devastating consequences of post-PCI stroke, patients with a history of TIA/stroke should be counseled on this increased risk before undergoing PCI.

Citing Articles

Long-term outcome of percutaneous or surgical revascularization with and without prior stroke in patients with three-vessel disease.

Xu N, Zhang C, Jiang L, Xu J, Liu R, Song Y J Geriatr Cardiol. 2022; 19(8):583-593.

PMID: 36339466 PMC: 9629998. DOI: 10.11909/j.issn.1671-5411.2022.08.001.

Outcomes between in-hospital stroke and community-onset stroke after thrombectomy: Propensity-score matching analysis.

Qiu K, Zu Q, Zhao L, Liu S, Shi H Interv Neuroradiol. 2021; 28(3):296-301.

PMID: 34516327 PMC: 9185103. DOI: 10.1177/15910199211030769.

Marijuana Use and In-Hospital Outcomes After Percutaneous Coronary Intervention in Michigan, United States.

Yoo S, Seth M, Vaduganathan M, Ruwende C, Karve M, Shah I JACC Cardiovasc Interv. 2021; 14(16):1757-1767.

PMID: 34412793 PMC: 8855440. DOI: 10.1016/j.jcin.2021.06.036.

Ten-year all-cause death following percutaneous or surgical revascularization in patients with prior cerebrovascular disease: insights from the SYNTAX Extended Survival study.

Wang R, Takahashi K, Garg S, Thuijs D, Kappetein A, Mack M Clin Res Cardiol. 2021; 110(10):1543-1553.

PMID: 33517534 PMC: 8484131. DOI: 10.1007/s00392-020-01802-x.

Stroke and spinal infarct caused by percutaneous coronary intervention.

Spindel J, Karmali D, Chen E, Ghafghazi S BMJ Case Rep. 2020; 13(6).

PMID: 32606119 PMC: 7328803. DOI: 10.1136/bcr-2020-234804.

References

Korn-Lubetzki I, Farkash R, Pachino R, Almagor Y, Tzivoni D, Meerkin D . Incidence and risk factors of cerebrovascular events following cardiac catheterization. J Am Heart Assoc. 2013; 2(6):e000413. PMC: 3886771. DOI: 10.1161/JAHA.113.000413. View

Elias-Smale S, Odink A, Wieberdink R, Hofman A, Hunink M, Krestin G . Carotid, aortic arch and coronary calcification are related to history of stroke: the Rotterdam Study. Atherosclerosis. 2010; 212(2):656-60. DOI: 10.1016/j.atherosclerosis.2010.06.037. View

Dukkipati S, ONeill W, Harjai K, Sanders W, Deo D, Boura J . Characteristics of cerebrovascular accidents after percutaneous coronary interventions. J Am Coll Cardiol. 2004; 43(7):1161-7. DOI: 10.1016/j.jacc.2003.11.033. View

Upadhya B, Sane D, Applegate R, Kutcher M, Gandhi S, Deliargyris E . Differences in baseline characteristics and in-hospital outcomes in patients with or without prior stroke undergoing percutaneous coronary intervention. J Invasive Cardiol. 2005; 17(5):243-7. View

Topcuoglu M, Saka E, Silverman S, Schwamm L, Singhal A . Recrudescence of Deficits After Stroke: Clinical and Imaging Phenotype, Triggers, and Risk Factors. JAMA Neurol. 2017; 74(9):1048-1055. PMC: 5710180. DOI: 10.1001/jamaneurol.2017.1668. View

Share D, Campbell D, Birkmeyer N, Prager R, Gurm H, Moscucci M . How a regional collaborative of hospitals and physicians in Michigan cut costs and improved the quality of care. Health Aff (Millwood). 2011; 30(4):636-45. DOI: 10.1377/hlthaff.2010.0526. View

Birkmeyer J, Gust C, Baser O, Dimick J, Sutherland J, Skinner J . Medicare payments for common inpatient procedures: implications for episode-based payment bundling. Health Serv Res. 2010; 45(6 Pt 1):1783-95. PMC: 3026958. DOI: 10.1111/j.1475-6773.2010.01150.x. View

Kline-Rogers E, Share D, Bondie D, Rogers B, Karavite D, Kanten S . Development of a multicenter interventional cardiology database: the Blue Cross Blue Shield of Michigan Cardiovascular Consortium (BMC2) experience. J Interv Cardiol. 2002; 15(5):387-92. DOI: 10.1111/j.1540-8183.2002.tb01072.x. View

Li Y, Rha S, Chen K, Jin Z, Minami Y, Wang L . Clinical characteristics and mid-term outcomes of acute myocardial infarction patients with prior cerebrovascular disease in an Asian population: Lessons from the Korea Acute Myocardial Infarction Registry. Clin Exp Pharmacol Physiol. 2010; 37(5-6):581-6. DOI: 10.1111/j.1440-1681.2010.05363.x. View

10.

Sasao H, Fujiwara H, Horiuchi N, Shirasaki S, Sakai I, Tsuchida K . Comparison of Long-Term Clinical Outcomes after Drug-Eluting Stent Implantation in Patients with Coronary Artery Disease with and without Prior Cerebral Infarction. Ann Vasc Dis. 2015; 8(2):79-86. PMC: 4485040. DOI: 10.3400/avd.oa.14-00137. View

11.

Wiviott S, Braunwald E, McCabe C, Montalescot G, Ruzyllo W, Gottlieb S . Prasugrel versus clopidogrel in patients with acute coronary syndromes. N Engl J Med. 2007; 357(20):2001-15. DOI: 10.1056/NEJMoa0706482. View

12.

Guduguntla V, Syrjamaki J, Ellimoottil C, Miller D, Prager R, Norton E . Drivers of Payment Variation in 90-Day Coronary Artery Bypass Grafting Episodes. JAMA Surg. 2017; 153(1):14-19. PMC: 5833620. DOI: 10.1001/jamasurg.2017.2881. View

13.

Cox A, Hsu F, Agarwal S, Freedman B, Herrington D, Carr J . Prediction of mortality using a multi-bed vascular calcification score in the Diabetes Heart Study. Cardiovasc Diabetol. 2014; 13:160. PMC: 4266952. DOI: 10.1186/s12933-014-0160-5. View

14.

Zhang M, Guddeti R, Wang S, Wang J, Xin M, Chen S . Prior ischemic stroke is not associated with worse clinical outcomes in patients undergoing percutaneous coronary intervention. Clin Invest Med. 2014; 37(4):E196-202. DOI: 10.25011/cim.v37i4.21724. View

15.

Moscucci M, Rogers E, Montoye C, Smith D, Share D, ODonnell M . Association of a continuous quality improvement initiative with practice and outcome variations of contemporary percutaneous coronary interventions. Circulation. 2006; 113(6):814-22. DOI: 10.1161/CIRCULATIONAHA.105.541995. View

16.

Song C, Sukul D, Seth M, Dupree J, Khandelwal A, Dixon S . Ninety-Day Readmission and Long-Term Mortality in Medicare Patients (≥65 Years) Treated With Ticagrelor Versus Prasugrel After Percutaneous Coronary Intervention (from the Blue Cross Blue Shield of Michigan Cardiovascular Consortium). Am J Cardiol. 2017; 120(11):1926-1932. PMC: 6850017. DOI: 10.1016/j.amjcard.2017.08.009. View

17.

Herrel L, Syrjamaki J, Linsell S, Miller D, Dupree J . Identifying Drivers of Episode Cost Variation With Radical Prostatectomy. Urology. 2016; 97:105-110. DOI: 10.1016/j.urology.2016.05.071. View

18.

Didier R, Gaglia Jr M, Koifman E, Kiramijyan S, Negi S, Omar A . Cerebrovascular accidents after percutaneous coronary interventions from 2002 to 2014: Incidence, outcomes, and associated variables. Am Heart J. 2016; 172:80-7. DOI: 10.1016/j.ahj.2015.10.019. View

19.

Morrow D, Braunwald E, Bonaca M, Ameriso S, Dalby A, Fish M . Vorapaxar in the secondary prevention of atherothrombotic events. N Engl J Med. 2012; 366(15):1404-13. DOI: 10.1056/NEJMoa1200933. View

20.

Jencks S, Williams M, Coleman E . Rehospitalizations among patients in the Medicare fee-for-service program. N Engl J Med. 2009; 360(14):1418-28. DOI: 10.1056/NEJMsa0803563. View